Corcept Therapeutics Incorporated
CORT
$115.70
$1.721.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 55.18M | 47.34M | 99.65M | 106.11M | 133.66M |
| Total Depreciation and Amortization | 2.42M | 2.03M | 1.89M | 1.87M | 1.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.17M | 44.53M | 41.86M | 48.11M | 15.16M |
| Change in Net Operating Assets | -24.07M | 26.56M | -1.41M | 7.51M | 31.72M |
| Cash from Operations | 109.70M | 120.45M | 142.00M | 163.61M | 182.42M |
| Capital Expenditure | -2.78M | -308.00K | -211.00K | -282.00K | -1.92M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.12M | 77.78M | 69.97M | 17.52M | -39.52M |
| Cash from Investing | -21.90M | 77.47M | 69.76M | 17.24M | -41.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.47M | 28.56M | 25.49M | 22.59M | 20.66M |
| Repurchase of Common Stock | -104.37M | -208.36M | -245.86M | -216.30M | -189.05M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -78.91M | -179.80M | -220.37M | -193.71M | -168.39M |
| Foreign Exchange rate Adjustments | -602.00K | 797.00K | 1.44M | 716.00K | 1.57M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.29M | 18.92M | -7.17M | -12.15M | -25.84M |